Innovative Targeted and Immune-Mediated Cancer Therapies

Pipeline

Developing first-in-class small molecule product candidates with broad potential benefit to patients

Learn more

Science

Modulating validated and new pathways to develop novel therapeutics

Learn more

News

January 7, 2021
Tempest Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

January 8, 2021
Tempest Therapeutics to Present at the H.C. Wainwright Virtual Bioconnect Conference

More news

Events

39th Annual J.P. Morgan Healthcare Conference
Thursday, January 14, 2021 at 2:00 pm Eastern Time

H.C. Wainwright Virtual BioConnect Conference
Monday, January 11, 2021 at 6:00 am Eastern Time